JUN 05, 2021 5:10 PM PDT

How is the new hospital price transparency rule going?

New findings from an analysis of hospital price transparency have been published recently in JAMA. The analysis was carried out by a team from Brigham and Women's Hospital and Massachusetts Eye and Ear following the introduction of a new requirement from The Centers for Medicare and Medicaid Services (CMS) that mandates that hospitals list their prices for services and items online. Despite this new requirement being a step in the right direction toward improving price transparency, the researchers’ analysis shows that it is not being regularly enforced.

"Reporting payer-negotiated prices is an important first step toward helping patients estimate the cost of care before receiving treatment," said corresponding author Roy Xiao, MD, MS, a resident in Otolaryngology-Head and Neck Surgery at the Brigham and Mass Eye and Ear. "Based on previous work, we expected to see some degree of variation, but the full range that we saw in our study was certainly surprising."

The study focused specifically on the price transparency and price variation for the treatment of thyroid cancer, which is known to be hugely expensive. Thyroid cancer patients boast the highest rates of bankruptcy among all cancer patients. The team’s analysis showed that only half of the cancer centers they looked at reported disclosing of payer-negotiated prices. Meanwhile, they also found a huge variation in prices between cancer care centers.

For example, between centers, they observed a 70-fold difference in the cost of radioactive iodine treatment and a 44-fold difference in the cost of neck computed tomography. They also saw a broad variation of prices even within the same center depending upon a patient’s health insurance.

Now, while this doesn’t necessarily shine a good light on hospitals and cancer care centers, the researchers say that it is important to take into account that they did their analysis soon after the introduction of the new requirement, meaning hospitals are still figuring out how to efficiently comply with the new rule. They have hope that disclosure rates and transparency will increase in the near future.

"Centers are facing a new reality when it comes to price transparency -- never before have they been required to make these rates available, and it's a huge lift to collect this information and make it available in a way that is intelligible to patients," said co-first author Vinay Rathi, MD, MBA, a resident in Otolaryngology-Head and Neck Surgery at the Brigham and Mass Eye and Ear. "As this information becomes available, we're interested in exploring how it can be used to help our patients."

Sources: JAMA, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 17, 2021
Clinical & Molecular DX
Delays in Breast Cancer Diagnoses Among Black Women
AUG 17, 2021
Delays in Breast Cancer Diagnoses Among Black Women
Thanks to breakthrough diagnostic technologies, we can now catch the early warning signs of breast cancer much faster th ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 21, 2021
Drug Discovery & Development
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
SEP 21, 2021
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
The innovative medical device manufacturer Boston Scientific recently showed success in treating patients with ...
OCT 28, 2021
Cancer
NF-κB: a Trick or a Treat for Cancer?
OCT 28, 2021
NF-κB: a Trick or a Treat for Cancer?
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T ...
NOV 08, 2021
Cancer
Genetic Explanation for Low Cancer Incidence in Elephants
NOV 08, 2021
Genetic Explanation for Low Cancer Incidence in Elephants
Elephants possess two qualities that might make one expect they are at high risk of developing cancer; they are large an ...
Loading Comments...